Dr. Valerie Theberge
Claim this profileCHU de Quebec-L'Hotel-Dieu de Quebec (HDQ)
Studies Breast Cancer
Studies Radiotherapy
6 reported clinical trials
14 drugs studied
Area of expertise
1Breast Cancer
Stage I
Stage II
HER2 negative
2Radiotherapy
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Valerie Theberge is currently running
Partial vs Whole Breast Irradiation
for Early-Stage Breast Cancer
The primary objective of this study is to determine in women with node negative BC ≤3cm in size, if PBI compared to WBI, both given once-a-day over 1 week following BCS, is non-inferior for LR and reduces adverse cosmesis. The primary outcomes are LR and patient-assessed cosmesis at 3 years post randomization.
Recruiting2 awards Phase 33 criteria
Radiation Therapy + Olaparib
for Breast Cancer
This phase II trial studies how well radiation therapy with or without olaparib works in treating patients with inflammatory breast cancer. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep cancer cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. It is not yet known whether radiation therapy with or without olaparib may work better in treating patients with inflammatory breast cancer.
Recruiting1 award Phase 248 criteria
More about Valerie Theberge
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Valerie Theberge has experience with
- Radiation
- Locoregional Radiation Treatment
- Regional Nodal XRT
- Chestwall XRT
- WBI
- No Radiation
Breakdown of trials Valerie Theberge has run
Breast Cancer
Radiotherapy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Valerie Theberge specialize in?
Valerie Theberge focuses on Breast Cancer and Radiotherapy. In particular, much of their work with Breast Cancer has involved Stage I patients, or patients who are Stage II.
Is Valerie Theberge currently recruiting for clinical trials?
Yes, Valerie Theberge is currently recruiting for 5 clinical trials in Quebec City Quebec. If you're interested in participating, you should apply.
Are there any treatments that Valerie Theberge has studied deeply?
Yes, Valerie Theberge has studied treatments such as Radiation, Locoregional radiation treatment, Regional Nodal XRT.
What is the best way to schedule an appointment with Valerie Theberge?
Apply for one of the trials that Valerie Theberge is conducting.
What is the office address of Valerie Theberge?
The office of Valerie Theberge is located at: CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Quebec City, Quebec G1R 2J6 Canada. This is the address for their practice at the CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.